Corvus Corporate Presentation February 2021 An immunology focused company developing drugs and antibodies that target the most critical cellular elements of the immune system Forward-Looking Statements / Safe Harbor 2 This presentation and the accompanying oral presentation contain "forward‐looking" statements, including statements related to the potential safety and efficacy of ciforadenant, CPI-006, CPI-818, the Company's ability to develop and advance product candidates into and successfully complete pre ...